One in five New Yorkers suffer from mental health disorders, but most of these people do not have access to treatment, especially in disadvantaged communities.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team.